Member Spotlight: Verve Biotech
Our September Member Spotlight features Verve Biotech, a biotechnology company with focus on venom research and contract research services. Read more
Our September Member Spotlight features Verve Biotech, a biotechnology company with focus on venom research and contract research services. Read more
Burlington Capital announced today that they have partnered with Invest Nebraska, a member of Bio Nebraska, to launch a new venture capital seed fund, Burlington Capital Ag-Venture. Read more
As the September NIAMRRE Member Spotlight, Bio Nebraska was given the opportunity to share its work with fellow NIAMRRE members Read more
Adjuvance Technologies, a member of Bio Nebraska, announced positive results in the first clinical trial of its adjuvant TQL-1055. Read more
GRAIL, a member of Bio Nebraska, has been acquired by Illumina, the global leader in DNA sequencing. GRAIL will continue to operate as a separate company. Read more
Pfizer, a member of Bio Nebraska, and BioNTech announced U.S. FDA approval of their COVID-19 vaccine that has been available for emergency use since December 2020. Read more
Bio Nebraska partnered with the ALSIC to present the 2021 Champion of Health Care Innovation Award to Rep. Don Bacon. Read more
Novozymes, a member of Bio Nebraska, announced today that they have committed to a $316 million investment in Blair, Neb. to produce plant-based products. Read more